Shizuoka, Japan

Yohei Yamamoto

This inventor holds 2 USPTO granted patents and 2 published patent applications. Top assignees: Chugai Pharmabody Research Pte. Ltd., Chugai Seiyaku Kabushiki Kaisha. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yohei Yamamoto. Retrieved from https://idiyas.com/inventor/yohei-yamamoto-2sy1jfvv

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Yohei Yamamoto: Innovator in Fusion Proteins

Introduction

Yohei Yamamoto is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of fusion proteins. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

One of his latest patents includes the development of ligand-binding fusion proteins, specifically targeting the CXCR3 ligand. This innovation has potential applications in therapeutic areas, showcasing his expertise in protein engineering.

Career Highlights

Throughout his career, Yohei has worked with prominent companies such as Chugai Seiyaku Kabushiki Kaisha and Chugai Pharmabody Research Pte. Ltd. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research in the field.

Collaborations

Yohei has collaborated with talented individuals, including Mika Sakurai and Kenta Haraya. These partnerships have fostered a creative environment that encourages innovation and the advancement of scientific knowledge.

Conclusion

In summary, Yohei Yamamoto is a distinguished inventor whose work in fusion proteins has made a significant impact in biotechnology. His patents and collaborations reflect his dedication to advancing the field and improving therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…